NPFCX
Price
$66.39
Change
+$0.02 (+0.03%)
Updated
Aug 27 closing price
Net Assets
158.54B
RPEBX
Price
$69.34
Change
+$0.02 (+0.03%)
Updated
Aug 27 closing price
Net Assets
158.54B
Interact to see
Advertisement

NPFCX vs RPEBX

Header iconNPFCX vs RPEBX Comparison
Open Charts NPFCX vs RPEBXBanner chart's image
American Funds New Perspective C
Price$66.39
Change+$0.02 (+0.03%)
VolumeN/A
Net Assets158.54B
American Funds New Perspective R2E
Price$69.34
Change+$0.02 (+0.03%)
VolumeN/A
Net Assets158.54B
NPFCX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NPFCX vs. RPEBX commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPFCX is a Buy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NPFCX (159B) and RPEBX (159B) have equal amount of cash in the bank . RPEBX pays higher dividends than NPFCX: RPEBX (0.12) vs NPFCX (0.00). NPFCX was incepted earlier than RPEBX: NPFCX (24 years) vs RPEBX (11 years). NPFCX (1.48) is less costly to investors than RPEBX (1.21). NPFCX (24.00) and RPEBX (24.00) have comparable annual turnover. NPFCX (250) and RPEBX (250) have matching initial minimum investment requirements. RPEBX (11.06) and NPFCX (10.56) have marching annual gain over last year. RPEBX return over 5 years is better than : 28.24 vs. NPFCX (25.82).
NPFCXRPEBXNPFCX / RPEBX
Total Expense Ratio1.481.21122%
Annual Report Gross Expense Ratio1.481.21122%
Fund Existence24 years11 years-
Gain YTD14.66314.85899%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets159B159B100%
Annual Yield % from dividends0.000.12-
Returns for 1 year10.5611.0695%
Returns for 3 years39.1940.6197%
Returns for 5 years25.8228.2491%
Returns for 10 years85.4988.3697%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGVT57.400.41
+0.72%
Ingevity Corp
BWB16.450.07
+0.43%
Bridgewater Bancshares
GTBP1.14N/A
N/A
GT Biopharma
CCK99.83-0.96
-0.95%
Crown Holdings
CATO3.90-0.05
-1.27%
CATO Corp